Tie-up is latest example of a big pharma group seeking to bolster rare disease portfolio
Home/FT/Johnson & Johnson to buy biotech Momenta in $6.5bn deal FT Johnson & Johnson to buy biotech Momenta in $6.5bn deal Financial Times0 Less than a minute Facebook X LinkedIn Tie-up is latest example of a big pharma group seeking to bolster rare disease portfolio Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Share on WhatsApp (Opens in new window) WhatsApp Email a link to a friend (Opens in new window) Email Related Financial Times0 Less than a minute Facebook X LinkedIn Facebook X LinkedIn Tumblr Pinterest Reddit VKontakte Share via Email Print